TRAF3 and stroke disorder: In discussing the role of epigenetic factors involving inflammation on the pathogenesis of ischemic injury, it should be remembered that the hypomethylation of TNF receptor–associated factor 3 (TRAF3) and protein phosphatase 1A (PPM1A) was associated with increased risk for stroke in patients treated with antiplatelet therapy [94,95].